Xcout IntelInbiomotion competitors & alternatives
The 12 closest competitors and alternatives to Inbiomotion among diagnostics companies — ranked by similarity to what Inbiomotion actually does, not by market-cap band.
Subscribe to see Inbiomotion’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Inbiomotion
Inbiomotion is a biotechnology research company based in Barcelona, Spain, that develops a single-gene-based diagnostic test providing objective predictive and prognostic data.
Inbiomotion at a glance
Inbiomotion is a diagnostics company headquartered in Spain. It has raised at least $4.7M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round closed in January 2021. Xcout tracks 9 named people at Inbiomotion, including Ralf van den Berg (Chief Operating Officer).
Inbiomotion leadership
- Ralf van den BergChief Operating Officer
- Joël Jean-MairetExecutive Chairman
- Prof Rob E. Coleman MD, MBBS, FRCP, FRCPEChairman
- Roger Gomisfounder
- Juan Carlos Tercero, PhDHead of Product Development
- David L. LaceyNon-Executive Director
3 more named people on record for Inbiomotion, with roles, board committees and tenure — see the full roster →
Inbiomotion funding rounds
At least $4.7M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | Undisclosed | 3 named | |
| — | $2.2M | 3 named | |
| Series A | $2.5M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Inbiomotion competitors
Ranked by semantic similarity — how close each company is to Inbiomotion by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Biohope is a commercial-stage biotechnology and R&D company based in Madrid, Spain, dedicated to developing precision medicine in vitro diagnostic tools for chronic medical conditions.
Biotechnology
Reveal Genomics, S.L. is a biotechnology company founded in 2020 and headquartered in Barcelona, Spain. The company develops innovative genomic tools to improve breast cancer treatment and personalized medicine.
Biotech
Health in Code is a Spanish company that provides genetic and genomic diagnostic services, including sequencing, bioinformatics, and clinical interpretation. It serves hospitals, clinical laboratories, healthcare professionals, and patients, with a focus on hereditary and rare diseases such as inherited cardiovascular conditions.
Biotech
IntegraGen develops genomic tests, molecular diagnostic products, and bioinformatics software for researchers, clinicians, and biopharma companies. The company specializes in oncology and genetic diseases, offering next-generation sequencing services, data analysis tools, and biomarker identification to support clinical research and diagnostics.
Biotechnology
EcoGenome LLC is a biotechnology company that develops diagnostic tests and kits for cancer, specifically focusing on prostate cancer. The company identifies individual tumor genetic vulnerabilities to help inform precise therapy planning and treatment choices for patients.
Biotechnology
Harmonigenic Corp. is a diagnostics and biotechnology company headquartered in Rochester, New York. The company brings radical innovation to personalized precision medicine, focusing on initial diagnostic and treatment decisions.
Healthcare & Biotechnology
Manlab is an Argentine biochemical and genomic diagnostic laboratory providing specialized medical testing and genetic analysis services.
Biotech
GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Biotechnology
Base4 Biosciences is a healthcare and AI startup based in Cabrils and Barcelona, Spain, specializing in AI-driven transcriptomic analysis for preventive medicine. The company has raised pre-seed funding to advance its diagnostic and analytical technologies.
Biotech, Diagnostics
Novigenix is an immuno-transcriptomics and TechBio company that provides precision oncology solutions for biopharmaceutical companies and researchers. It offers LITOseek, an AI-powered liquid biopsy platform that analyzes gene activity in immune cells to support biomarker discovery, therapy development, and patient response monitoring.
Biotechnology
Predicine Holdings Ltd provides next-generation liquid biopsy platforms and molecular profiling services for cancer research and precision medicine. The company utilizes proprietary blood- and urine-based assays to analyze circulating tumor DNA and RNA, serving biopharmaceutical partners and clinical researchers in oncology drug development and clinical trials.
Biotechnology
ImmunArray is a privately funded molecular diagnostics company co-located in Rehovot, Israel, and Richmond, Virginia. Founded in 2005, the company is dedicated to the development of novel blood-based tests and diagnostic solutions.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Inbiomotion and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Inbiomotionand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →